Search

Your search keyword '"Leppert, D."' showing total 292 results

Search Constraints

Start Over You searched for: Author "Leppert, D." Remove constraint Author: "Leppert, D."
292 results on '"Leppert, D."'

Search Results

1. Ofatumumab versus Teriflunomide in Multiple Sclerosis

2. Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis

5. Serum neurofilament light and tau as markers for overall mortality in the elderly general population – an analysis from the MEMO cohort study

6. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

7. Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity

13. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

17. Neurofilament results for the phase II neuroprotection study of phenytoin in optic neuritis.

18. PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis

19. SMA THERAPIES II AND BIOMARKERS

20. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures

21. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

25. Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis

29. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins

30. Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome

32. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study

34. Long-Term Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Week 96 Results of a Phase II, Randomized, Multicenter Trial (S30.006)

36. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.

37. Medial medullary syndrome due to vertebral artery dissection

Catalog

Books, media, physical & digital resources